Other
Stellate Ganglion Block
0
Pipeline Programs↗
7
Active Trials↗
0
Companies Involved↗
Stellate Ganglion Block is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
25
clinical trials
Completed14 · 56%
Not yet recruiting5 · 20%
Unknown status3 · 12%
Recruiting2 · 8%
Withdrawn1 · 4%
Clinical Trials
Trial Activity
25 trials
Combining Stellate Ganglion Block With Prolonged Exposure for PTSD
Recruiting·TThe University of Texas Health Science Center at San Antonio·Phase 2·NCT05889741·140 enrolled
Stellate Ganglion Block in Longstanding Facial Nerve Palsy Patients
Not yet recruiting·—·N/A·NCT06742255·34 enrolled
Effectiveness of Stellate Ganglion Block in Patients Diagnosed With Parkinson's Disease
Not yet recruiting·—·N/A·NCT06319625·80 enrolled
Stellate Ganglion Block as Adjuvant Therapy to ca Channel Blocker
Completed·—·Phase 2·NCT04100824·40 enrolled
Effect of Stellate Ganglion Block on Internal Mammary Artery Dynamics
Completed·—·N/A·NCT05952011·70 enrolled
Augmenting Massed Prolonged Exposure With a Stellate Ganglion Block to Treat PTSD
Completed·TThe University of Texas Health Science Center at San Antonio·Phase 1·NCT04302181·12 enrolled
Stellate Ganglion Block Using Ultrasound Guidance For Treatment Of Post Clipping Cerebral Vasospasm
Completed·PPost Graduate Institute of Medical Education and Research, Chandigarh·Phase 1·NCT02775318·20 enrolled
Ultrasound-Guided Stellate Ganglion Block With Botulinum
Completed·—·N/A·NCT05099835·60 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)